BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2444333)

  • 21. Correlation of C3d fixing circulating immune complexes with disease activity and clinical parameters in patients with systemic lupus erythematosus.
    Sekita K; Doi T; Muso E; Yoshida H; Kanatsu K; Hamashima Y
    Clin Exp Immunol; 1984 Mar; 55(3):487-94. PubMed ID: 6608422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
    Greisman SG; Redecha PB; Kimberly RP; Christian CL
    J Immunol; 1987 Feb; 138(3):739-45. PubMed ID: 3492531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
    Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
    Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE; Moss IK; Mumford P; Horsfall A; Maini RN
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of circulating immune complexes by chicken anti-C4 micro ELISA.
    Larsson A; Sjöquist J
    J Clin Lab Immunol; 1988 Sep; 27(1):39-43. PubMed ID: 3150766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Circulating immune complexes and bronchopulmonary cancers].
    Pourrat JP; Leophonte P; Pourrat E; Mouysset B; Conte JJ; Delaude A
    Rev Mal Respir; 1984; 1(1):31-6. PubMed ID: 6611568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of complement components in polyethylene glycol precipitated immune complexes from patients with ovarian cancer and patients with rheumatoid arthritis.
    Mooney NA; Hay FC; Poulton TA
    Clin Exp Immunol; 1983 Jun; 52(3):561-8. PubMed ID: 6603297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncofetal expression of Lex carbohydrate antigens in human colonic adenocarcinomas. Regulation through type 2 core chain synthesis rather than fucosylation.
    Holmes EH; Ostrander GK; Clausen H; Graem N
    J Biol Chem; 1987 Aug; 262(23):11331-8. PubMed ID: 3112156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lewisx- and sialylated Lewisx-related antigen expression in human malignant and nonmalignant colonic tissues.
    Itzkowitz SH; Yuan M; Fukushi Y; Palekar A; Phelps PC; Shamsuddin AM; Trump BF; Hakomori S; Kim YS
    Cancer Res; 1986 May; 46(5):2627-32. PubMed ID: 3516383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of circulating immune complexes in patients with squamous cell carcinoma of the oral cavity.
    Mukhopadhyaya R; Rao RS; Fakih AR; Gangal SG
    J Clin Lab Immunol; 1986 Dec; 21(4):189-93. PubMed ID: 3494132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating immune complexes in patients with diabetes mellitus.
    Abrass CK; Heber D; Lieberman J
    Clin Exp Immunol; 1983 Apr; 52(1):164-72. PubMed ID: 6305541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-C1q affinity isolated circulating immune complexes correlate with extra-articular rheumatoid disease.
    Melsom RD; Horsfall AC; Schrieber L; Charles P; Maini RN
    Rheumatol Int; 1986; 6(5):227-31. PubMed ID: 3492027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune complexes and complement components in Bell's palsy.
    Jonsson L; Larsson A; Thomander L
    ORL J Otorhinolaryngol Relat Spec; 1987; 49(6):294-301. PubMed ID: 3501560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgA containing immune complexes in dogs bearing a spontaneous mammary adenocarcinoma.
    Balint J; Nagai T; Ikeda Y; Meek K; Terman DS
    Clin Exp Immunol; 1982 Aug; 49(2):433-40. PubMed ID: 6982137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of immune complexes detected by the 125I-C1q binding assay in breast cancer.
    Krieger G; Kneba M; Bolz I; Nagel GA
    Clin Immunol Immunopathol; 1988 Jan; 46(1):14-23. PubMed ID: 3257175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measurement of serum antibodies to C1q and conglutinin in rabbits following feeding with cows' milk and in normal human serum.
    Hanglow AC; Welsh CJ; Coombs RR
    Adv Exp Med Biol; 1987; 216B():1317-23. PubMed ID: 3501233
    [No Abstract]   [Full Text] [Related]  

  • 40. Complement C1q binding affects spin-labeled heterosaccharides of rabbit antibodies in immune but not artificial immunoglobulin G aggregates.
    Winkelhake JL; Kusumi A; McKean L; Mandy WJ
    J Biol Chem; 1984 Feb; 259(4):2171-8. PubMed ID: 6199346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.